Last Updated: September 24, 2026

ERGOLOID MESYLATES - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for ERGOLOID MESYLATES
Drug Prices for ERGOLOID MESYLATES

See drug prices for ERGOLOID MESYLATES

Recent Clinical Trials for ERGOLOID MESYLATES

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Elizabeth Berry-KravisPhase 2
Sinphar Pharmaceutical Co., LtdPhase 2

See all ERGOLOID MESYLATES clinical trials

Medical Subject Heading (MeSH) Categories for ERGOLOID MESYLATES
Anatomical Therapeutic Chemical (ATC) Classes for ERGOLOID MESYLATES

US Patents and Regulatory Information for ERGOLOID MESYLATES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms HYDROGENATED ERGOT ALKALOIDS ergoloid mesylates TABLET;SUBLINGUAL 087185-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sandoz ALKERGOT ergoloid mesylates TABLET;SUBLINGUAL 085153-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs GERIMAL ergoloid mesylates TABLET;SUBLINGUAL 086189-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novartis HYDERGINE ergoloid mesylates TABLET;SUBLINGUAL 009087-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novartis HYDERGINE ergoloid mesylates TABLET;SUBLINGUAL 009087-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novartis HYDERGINE ergoloid mesylates TABLET;ORAL 017993-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ERGOLOID MESYLATES

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis HYDERGINE LC ergoloid mesylates CAPSULE;ORAL 018706-001 Jan 18, 1983 4,366,145 ⤷  Start Trial
Novartis HYDERGINE ergoloid mesylates SOLUTION;ORAL 018418-001 Approved Prior to Jan 1, 1982 4,138,565 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.